US President Donald Trump, with Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, and Joe Gebbia, director of the National Design Studio, at the White House in Washington, on February 5, 2026. NATHAN HOWARD/GETTY IMAGES VIA AFP
"Find the world's lowest prices on prescription drugs." That is the promise of TrumpRx, the new website unveiled on Friday, February 6, by the White House to provide American patients with a selection of discounted treatments, displayed in bold letters on the platform's homepage. Announced in September, the initiative aims to symbolize the administration's yearlong efforts to lower healthcare costs in the United States.
The launch of the website, which features discounts ranging from 33% to 93%, followed a series of confidential agreements reached in recent months between Washington and 17 major pharmaceutical companies worldwide. The pharmaceutical groups committed, among other things, to selling some of their products directly at prices significantly below the standard rates for patients paying out of pocket, that is, without any reimbursement from their health insurance. Serving as a platform connecting patients and pharmaceutical companies, TrumpRx is ultimately expected to consolidate all the offers made available by each drug manufacturer.
